| 產(chǎn)品名稱 | Triple-Negative Breast Cancer Panel 2; Mesenchymal & Luminal Morphology |
|---|---|
| 商品貨號 | B197846 |
| Organism | Homo sapiens, human |
| Components | BT-549, ATCC HTB-122 Hs 578T ATCC HTB-126 MDA-MB-231 ATCC HTB-26 MDA-MB-436 ATCC HTB-130 MDA-MB-157 ATCC HTB-24 MDA-MB-453 ATCC HTB-131 |
| Applications | Biological understanding of top genetic alterations across tumor types Testing small molecules or biologics for cancer drug development Validation and characterization of potential cancer driver genes Functional profiling and molecular profiling of subtype-specific cancer cell lines |
| Type Strain | no |
| Biosafety Level | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments | A panel of 6 triple-negative breast tumor cell lines sharing a mesenchymal-like or luminal morphology. See J Clinical Inv (2011) 121(7):2750-2767 for more information. Ref   Lehmann BD, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121: 2750-2767, 2011. PubMed: 21633166 |
| Product Format | frozen |
| Storage Conditions | LN vapor (less than -130°C) only |
| 梅經(jīng)理 | 17280875617 | 1438578920 |
| 胡經(jīng)理 | 13345964880 | 2438244627 |
| 周經(jīng)理 | 17757487661 | 1296385441 |
| 于經(jīng)理 | 18067160830 | 2088210172 |
| 沈經(jīng)理 | 19548299266 | 2662369050 |
| 李經(jīng)理 | 13626845108 | 972239479 |
